Phreesia, Inc. (NYSE:PHR) Given Average Rating of “Hold” by Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have been assigned a consensus rating of “Hold” from the nineteen research firms that are presently covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, nine have given a hold rating and nine have assigned a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $16.6471.

PHR has been the topic of several research analyst reports. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $16.00 price objective (down from $24.00) on shares of Phreesia in a research note on Tuesday, March 31st. Stephens dropped their price objective on Phreesia from $32.00 to $20.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 31st. Robert W. Baird reissued a “neutral” rating and issued a $10.00 price objective (down from $25.00) on shares of Phreesia in a research note on Tuesday, March 31st. Citizens Jmp reissued a “market perform” rating on shares of Phreesia in a research note on Wednesday, April 1st. Finally, Canaccord Genuity Group dropped their price objective on Phreesia from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Thursday.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia reported fiscal Q1 2027 results that beat Wall Street expectations, with EPS of $0.05 versus $0.02 expected and revenue of $130.94 million above estimates; the company also cited 12.9% year-over-year revenue growth, which is helping sentiment. Article Title
• Positive Sentiment: The company also issued FY2027 revenue guidance of $510 million to $520 million, which is roughly in line with consensus and suggests management sees continued growth ahead. Article Title
• Positive Sentiment: Analysts reacted favorably overall, with DA Davidson reaffirming a Buy rating and Piper Sandler still seeing upside even after a downgrade to Neutral. Article Title
• Neutral Sentiment: Several law firms are publicizing a pending securities class action and a July 13, 2026 lead-plaintiff deadline for investors who bought Phreesia shares during the class period. These notices add headline risk, but they are procedural updates rather than new company operating news. Article Title
• Neutral Sentiment: Market coverage also noted that Phreesia shares rose after the earnings and revenue beat, reinforcing that the stock’s move is being driven mainly by the stronger-than-expected quarterly results. Article Title

Phreesia Trading Up 3.7%

Shares of NYSE PHR opened at $9.80 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.53 and a current ratio of 1.53. The business’s 50 day moving average price is $9.46 and its 200-day moving average price is $13.57. Phreesia has a fifty-two week low of $7.77 and a fifty-two week high of $32.76. The company has a market cap of $605.28 million, a price-to-earnings ratio of 65.33 and a beta of 0.89.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Wednesday, May 27th. The company reported $0.05 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.02 by $0.03. Phreesia had a return on equity of 5.30% and a net margin of 1.85%.The company had revenue of $130.94 million for the quarter, compared to analysts’ expectations of $130.08 million. During the same quarter in the prior year, the firm earned ($0.07) earnings per share. Phreesia’s revenue was up 12.9% compared to the same quarter last year. On average, sell-side analysts expect that Phreesia will post 0.28 earnings per share for the current year.

Insider Transactions at Phreesia

In other Phreesia news, General Counsel Allison C. Hoffman sold 14,483 shares of the stock in a transaction on Friday, April 10th. The stock was sold at an average price of $8.07, for a total transaction of $116,877.81. Following the sale, the general counsel owned 163,485 shares of the company’s stock, valued at approximately $1,319,323.95. This trade represents a 8.14% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Balaji Gandhi sold 3,829 shares of the stock in a transaction on Wednesday, March 25th. The shares were sold at an average price of $11.26, for a total value of $43,114.54. Following the sale, the chief financial officer directly owned 146,740 shares in the company, valued at $1,652,292.40. This trade represents a 2.54% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 50,493 shares of company stock worth $461,983 in the last ninety days. 5.20% of the stock is owned by company insiders.

Institutional Trading of Phreesia

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Vanguard Group Inc. boosted its position in Phreesia by 8.3% during the 3rd quarter. Vanguard Group Inc. now owns 5,704,786 shares of the company’s stock valued at $134,177,000 after acquiring an additional 437,462 shares in the last quarter. New York State Common Retirement Fund boosted its position in Phreesia by 727.1% during the 3rd quarter. New York State Common Retirement Fund now owns 136,856 shares of the company’s stock valued at $3,219,000 after acquiring an additional 120,309 shares in the last quarter. Greenhouse Funds LLLP boosted its position in Phreesia by 16.8% during the 3rd quarter. Greenhouse Funds LLLP now owns 3,882,527 shares of the company’s stock valued at $91,317,000 after acquiring an additional 557,265 shares in the last quarter. SG Americas Securities LLC bought a new stake in Phreesia during the 4th quarter valued at $1,203,000. Finally, Bessemer Group Inc. boosted its position in Phreesia by 1,065.9% during the 3rd quarter. Bessemer Group Inc. now owns 554,513 shares of the company’s stock valued at $13,043,000 after acquiring an additional 506,954 shares in the last quarter. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.